A) Identification of regions of M2 responsible for decreased ENaC activity. Amino acid sequence of the A/Udorn/1972 M2 protein and the points of truncation for each construct are shown. The 3 protein domains are indicated above the sequence. B) Xenopus oocytes were coinjected with α-, β-, and γ-hENaC cRNAs and sterile water or with α-, β-, and γ-hENaC cRNAs plus either the full-length M2 or truncated M2 cRNAs. Forty-eight hours later, IENaC (left panel) and IM2 (right panel) were recorded. Values were obtained at a membrane potential of −100 mV and are means ± 1 se; n = ≥21. *P < 0.01 vs. control; #P < 0.01 vs. corresponding ENaC or M2. B) MG-132 reverses the M2 effect on ENaCs. Oocytes were injected with α-, β-, and γ-hENaC or α-, β-, and γ-hENaC and M2 cRNAs. In some cases, MG-132 (40 nM) was added in the medium immediately after injection. Whole-cell currents were recorded 48 h later, and IENaC was calculated as described in Materials and Methods. Values are means ± se; n = number of measurements. C) M2 does not down-regulate ENaCs with Liddle mutations. Xenopus oocytes were injected with α-, β-, and γ-ENaC cRNAs with the Liddle mutation alone or Liddle ENaC and M2 cRNAs. IENaC was recorded as described in Materials and Methods. Values are means ± 1 se; n = number of measurements.